
Photo: depositphotos.com
Apr 18, 2025, 02:06
Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC
International Association for the Study of Lung Cancer shared a post on LinkedIn:
“This study from Tavernari et al. highlights the need to identify uncommon mutations of EGFR to inform therapeutic decisions.
Given the tobacco-related molecular signatures and high tumor mutational burden associated with this subgroup, further investigation is warranted.”
Authors: Daniele Tavernari, Alfredo Addeo, et al.
More posts featuring International Association for the Study of Lung Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 12, 2025, 15:29
May 12, 2025, 15:13
May 12, 2025, 15:01
May 12, 2025, 14:47
May 12, 2025, 14:34
May 12, 2025, 14:25